Study ID: NC-100
Study Title
- A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.
Teva Identifier
- NC-100
ClinicalTrials.gov Identifier
- NCT00203073
Study Status
- Completed
Trial Condition(s)
- Relapsing Remitting Multiple Sclerosis
Interventions
- Drug: glatiramer acetate 20 mg | Drug: glatiramer acetate 20 mg, with mitoxantrone
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 55 Years
Trial Duration
- 06/01/2003 - 04/01/2005
Phase
- Phase 2
Study Type
Interventional
